EUVIMEDEUVIMED entdecken
Crossref

A Review Article on the Bioavailability of Lumateperone

J Ben Samuel, S Jebaseelan

International Journal of Science and Research (IJSR) · 24.06.2026 · 1112-1112

DOI: 10.21275/sr26618191859 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Science and Research (IJSR), erschienen am 24.06.2026. Verfasst von J Ben Samuel und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lumateperone is a recently approved second generation antipsychotic developed for the treatment of schizophrenia. Its pharmacological profile differs from conventional agents because it acts on serotonergic, dopaminergic, and glutamatergic pathways at the same time. The drug shows high affinity for 5 HT2A receptors, moderate affinity for D2 receptors, and low affinity for H1 and 5 HT2C receptors, which may contribute to its therapeutic effects and tolerability. Lumateperone functions as a presynaptic D2 partial agonist and postsynaptic D2 antagonist, helping regulate dopamine activity in brain regions associated with schizophrenia. It also enhances NMDA mediated glutamate signaling and modulates serotonin through serotonin transporter inhibition and 5 HT2A receptor blockade. The drug has an oral bioavailability of about 4.4 percent and reaches peak plasma concentration within one to two hours, while steady state levels are achieved after five days of repeated dosing. Extensive metabolism produces more than twenty metabolites, with elimination occurring mainly through urine. Its terminal half- life is approximately eighteen hours. The distinct mechanism of action and favorable pharmacokinetic profile make lumateperone a promising option for managing both positive and negative symptoms of schizophrenia.

Zitieren

APA

Samuel, J. B., & Jebaseelan, S. (2026). A Review Article on the Bioavailability of Lumateperone. International Journal of Science and Research (IJSR), 1112-1112. https://doi.org/10.21275/sr26618191859

Vancouver

Samuel JB, Jebaseelan S. A Review Article on the Bioavailability of Lumateperone. International Journal of Science and Research (IJSR). 2026:1112-1112. doi:10.21275/sr26618191859

BibTeX
@article{Samuel2026,
  author = {Samuel, J Ben and Jebaseelan, S},
  title = {A Review Article on the Bioavailability of Lumateperone},
  journal = {International Journal of Science and Research (IJSR)},
  year = {2026},
  pages = {1112--1112},
  doi = {10.21275/sr26618191859}
}
Kostenlos starten →